{"doi":"10.1007/s10555-007-9044-4","title":"The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs","abstract":null,"journal":"Cancer and Metastasis Reviews","year":2007,"id":19611,"datarank":9.478235211762062,"base_score":5.442417710521793,"endowment":5.442417710521793,"self_citation_contribution":0.8163626565782691,"citation_network_contribution":8.661872555183793,"self_endowment_contribution":0.8163626565782691,"citer_contribution":8.661872555183793,"corpus_percentile":null,"corpus_rank":null,"citation_count":230,"citer_count":200,"citers_with_citation_signal":183,"citers_with_endowment":183,"datacite_reuse_total":2,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":132270,"name":"Frank Visser","orcid":null,"position":1,"is_corresponding":false},{"id":132272,"name":"Karen M. King","orcid":null,"position":2,"is_corresponding":false},{"id":132274,"name":"Stephen A. Baldwin","orcid":null,"position":3,"is_corresponding":false},{"id":132276,"name":"James D. Young","orcid":null,"position":4,"is_corresponding":false},{"id":132277,"name":"Carol E. Cass","orcid":null,"position":5,"is_corresponding":false},{"id":13180,"name":"Jing Zhang","orcid":"0000-0002-5970-0509","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":5.442417710521793,"endowment":5.442417710521793,"datacite_reuse_total":2,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"17345146","pmcid":null,"openalex_id":"https://openalex.org/W2070851085","authors":[],"funders":[{"funder_name":"Natural Sciences and Engineering Research Council of Canada","grant_id":"unidentified","title":"unidentified"}],"total_grants":1,"fwci":11.1929,"citation_percentile":0.99380229,"influential_citations":7,"citation_trend":[{"year":2012,"count":11},{"year":2013,"count":12},{"year":2014,"count":11},{"year":2015,"count":10},{"year":2016,"count":18},{"year":2017,"count":14},{"year":2018,"count":16},{"year":2019,"count":12},{"year":2020,"count":14},{"year":2021,"count":7},{"year":2022,"count":10},{"year":2023,"count":10},{"year":2024,"count":7},{"year":2025,"count":6},{"year":2026,"count":1}],"oa_status":"closed","license":"Springer TDM","oa_locations":[{"url":"http://link.springer.com/content/pdf/10.1007/s10555-007-9044-4.pdf","host_type":"publisher"},{"url":"http://link.springer.com/article/10.1007/s10555-007-9044-4/fulltext.html","host_type":"publisher"},{"url":"http://link.springer.com/content/pdf/10.1007/s10555-007-9044-4","host_type":"publisher"},{"url":"https://doi.org/10.1007/s10555-007-9044-4","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/17345146","host_type":"repository"},{"url":"https://dx.doi.org/10.1007/s10555-007-9044-4","host_type":""}],"fields_of_study":["Adenosine and Purinergic Signaling","HIV/AIDS drug development and treatment","Neuroendocrine Tumor Research Advances","Biology","Medicine","Chemistry","0301 basic medicine","0303 health sciences","03 medical and health sciences","Animals","Antineoplastic Agents","Biological Transport","Humans","Neoplasms","Nucleoside Transport Proteins","Nucleosides","Structure-Activity Relationship"],"mesh_terms":["Animals","Antineoplastic Agents","Biological Transport","Humans","Neoplasms","Nucleosides","Structure-Activity Relationship","Nucleoside Transport Proteins"],"keywords":["Nucleoside","Nucleoside analogue","Nucleoside transporter","Transporter","Pharmacology","Drug resistance","Biology","Chemistry","Biochemistry","Gene","Genetics","Structure-Activity Relationship","Neoplasms","Animals","Humans","Antineoplastic Agents","Biological Transport","Nucleosides","Nucleoside Transport Proteins"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.13578760.v1","title":"Additional file 1 of Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.13578760","title":"Additional file 1 of Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance","publisher":"figshare","resource_type":"JournalArticle"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-04T05:01:49.545405Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}